Understanding how diabetes affects insulin-producing cells in the pancreas
Beta cell exhaustion and glucotoxicity in Diabetes
This study is looking into how insulin-producing cells in people with diabetes can change and stop working properly, rather than just dying off, and it aims to find ways to help these cells recover and improve diabetes treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11072878 on NIH RePORTER |
What this research studies
This research investigates the loss and dysfunction of insulin-producing beta cells in diabetes, focusing on how these cells can lose their identity rather than just die. The study aims to uncover the mechanisms behind this process and identify potential windows for intervention to restore beta cell function. Using advanced mouse models, researchers will explore how metabolic changes impact beta cell health and the role of autophagy in preventing cell failure due to high blood sugar levels. The goal is to provide insights that could lead to new treatments for diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with adult-onset diabetes who may benefit from interventions aimed at preserving beta cell function.
Not a fit: Patients with type 1 diabetes or those who have already experienced irreversible beta cell loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preserving or restoring insulin-producing cells in diabetes patients.
How similar studies have performed: Previous research has shown promising results in understanding beta cell identity loss, suggesting that this approach could yield significant insights.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Remedi, Maria Sara — Washington University
- Study coordinator: Remedi, Maria Sara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.